// App-Quantinova.ai

700P : Comparison of prognostic models for hepatocellular carcinoma (HCC) in patients treated with the sorafenib: Results from a Canadian multi-center HCC database

Researchers

Presenter

  • H.H.Samawi

Principal Investigators

  • S.Hao-Wen

  • K.Chan

  • M.A.Alghamdi

  • R.M.Lee-Ying

  • J.Knox

  • P.Gill

  • A.Romagnino

  • E.Batuyong

  • Y-J.Ko

  • W.Y.Cheung

  • V.C.Tam

Medical Centers

  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada

  • Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

  • Division of Medical Oncology/Hematology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada

  • Medical Oncology, Tom Baker Cancer Center, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Sorafenib

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved